
FDA Releases Supply Chain Guidance
The agency published guidance on identifying trading partners under DSCSA.
On August 18, 2017, FDA published
DSCSA requires manufacturers, repackagers, wholesale distributors, and dispensers to meet certain requirements in order to be considered authorized trading partners. The guidance defines drug supply entities under DSCSA, what qualifies these entities as authorized partners, and outlines the licensure and reporting requirements for such entities, going into specifics on how to identify each type of partner in the supply chain.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.